CEUAX | TIOIX | CEUAX / TIOIX | |
Total Expense Ratio | 0.86 | 0.60 | 143% |
Annual Report Gross Expense Ratio | 0.86 | 0.60 | 143% |
Fund Existence | 23 years | 12 years | - |
Gain YTD | -0.038 | -1.295 | 3% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 120B | 2.17B | 5,522% |
Annual Yield % from dividends | 1.11 | 1.49 | 74% |
Returns for 1 year | -4.00 | -0.51 | 779% |
Returns for 3 years | 1.69 | -1.36 | -124% |
Returns for 5 years | 22.63 | 26.44 | 86% |
Returns for 10 years | 17.24 | 38.13 | 45% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BEOIX | 8.09 | 0.11 | +1.38% |
Barrow Hanley Concentrated EM ESG Opps I | |||
FIJZX | 42.83 | 0.37 | +0.87% |
Fidelity Advisor Consumer Discret Z | |||
IVGSX | 20.60 | 0.03 | +0.15% |
VY® Invesco Growth and Income S | |||
JFNAX | 63.10 | 0.02 | +0.03% |
Janus Henderson Global Life Sciences A | |||
ITGIX | 84.30 | -0.28 | -0.33% |
VY® T. Rowe Price Growth Equity I |